Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 1Phase 3 1Phase 2/3 1

Status

Terminated 7Withdrawn 6Completed 6Unknown 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Plasma cell 1

Conditions

Breast Neoplasms 111Carcinoma, Non-Small-Cell Lung 102Prostatic Neoplasms 66Multiple Myeloma 64Neoplasm Metastasis 63Colorectal Neoplasms 63Neoplasms 59Lung Neoplasms 52Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 41Recurrence 40Lymphoma 40Leukemia, Lymphocytic, Chronic, B-Cell 36Pancreatic Neoplasms 34Melanoma 34Head and Neck Neoplasms 27Glioblastoma 26Rectal Neoplasms 25Ovarian Neoplasms 25Lymphoma, Large B-Cell, Diffuse 25Leukemia 24Brain Neoplasms 24Squamous Cell Carcinoma of Head and Neck 23Hematologic Neoplasms 23Carcinoma, Renal Cell 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Myelodysplastic Syndromes 20Colonic Neoplasms 20Triple Negative Breast Neoplasms 19Lymphoma, Non-Hodgkin 19

Interventions

Hydroxychloroquine 2palbociclib 1ogalvibart 1crexavibart 1cilgavimab and tixagevimab drug combination 1Azithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × COVID-19 × Clear all
NCT04379492 2025-05-16

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn

COVID-19

NCT05465876 2024-04-04

PACE-CLL

Sunnybrook Health Sciences Centre

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05125562 2024-02-13

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

Direct Biologics, LLC

Phase 2 Withdrawn
Lymphoid

COVID-19, Lymphoma, Follicular

NCT05393999 2023-04-24

SABRE

Imperial College Healthcare NHS Trust

Phase 2 Withdrawn
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT05371275 2022-11-07

CDK6COV

biotx.ai GmbH

Phase 2 Withdrawn
Lymphoid

COVID-19, Lymphoma, Follicular

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡